Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland — I. García‐Doval (2018) | RDL Network
Cumulative exposure to biological therapy and risk of cancer in patients with psoriasis: a meta-analysis of Psonet studies from Israel, Italy, Spain, the U.K. and Republic of Ireland
Article 2018 en
Authors
IG
I. García‐Doval
MD
M.Á. Descalzo
KM
K.J. Mason
Abstract
1 min read
Cumulative length of exposure to biological therapies in patients with psoriasis in real-world clinical practice does not appear to be linked to a higher risk of cancer after several years of use.
I. García‐Doval, M.Á. Descalzo, Kimberly Mason, Adam D. Cohen, A.D. Ormerod, Francisco Gómez‐García, Simone Cazzaniga, Ilan Feldhamer, Hasan Ali, Enrique Herrera‐Acosta, Christopher Em Griffiths, Roni Stern, Luigi Naldi
Zenas Z N Yiu, K.J. Mason, Juliet N. Barker, Philip Hampton, Kathleen McElhone, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Mark Lunt, A. David Burden
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.